SCHEMBL29458522

SCHEMBL29458522

CC(C)n1c(=O)[nH]c(=O)c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.64
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTT P42858 1/20 0.45
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCI P41743 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCZ Q05513 1/20 0.44
PRKCD Q05655 1/20 0.44
PRKD1 Q15139 1/20 0.44
PGR P06401 4/20 0.43
PARP1 P09874 3/20 0.43
CYP1A2 P05177 2/20 0.43
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14227440 1.00 POLB (0.64) POLBALDH1A1L3MBTL1HTTPRKD3
SCHEMBL14227443 0.81 POLB (0.54) POLBALDH1A1L3MBTL1PGRMAPT
SCHEMBL11996665 0.81 POLB (0.43) POLBPARP1CYP1A2MAT2AMEN1
SCHEMBL6802306 0.78 DAO (0.40) POLBALDH1A1PARP1CYP1A2MAT2A
SCHEMBL11187570 0.78 NR1I2 (0.48) POLBPGRPARP1MAT2ALMNA
SCHEMBL30838374 0.78 POLB (1.00) POLBALDH1A1L3MBTL1PGRCYP1A2
SCHEMBL828232 0.78 POLB (1.00) POLBALDH1A1L3MBTL1PGRCYP1A2
SCHEMBL29458471 0.77 PGR (0.54) POLBPGR
SCHEMBL9432792 0.77 POLB (0.62) POLBALDH1A1PARP1CYP1A2MAT2A
SCHEMBL8472323 0.77 POLB (0.39) POLBALDH1A1PARP1CYP1A2MAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220081422-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 2022-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220081422-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD POLB 396/4885ALDH1A1 118/4885L3MBTL1 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.